Literature DB >> 6447998

In-vitro inactivation of aminoglycoside antibiotics by piperacillin and carbenicillin.

D C Hale, R Jenkins, J M Matsen.   

Abstract

Clinical microbiology laboratory experiences wherein aminoglycoside serum assay results appeared inconsistent with the amount of the compound given when administered in combination with a semisynthetic penicillin led us to compare the interaction of three currently available aminoglycoside antibiotics with carbenicillin, as a representative semisynthetic penicillin given in large doses, and with piperacillin, a new broad-spectrum semisynthetic penicillin. Amikacin, gentamicin, and tobramycin were incubated in serum in vitro with various concentrations of carbenicillin and piperacillin. In the presence of very high concentrations of the two penicillins, tobramycin was the most rapidly inactivated aminoglycoside, gentamicin was next, and amikacin was only slightly inactivated. With low concentrations of the two penicillins, the rates of aminoglycoside inactivation were negligible. Carbenicillin, in high concentration, inactivated the aminoglycosides more rapidly than piperacillin. In patients experiencing renal failure, the maintenance of moderate serum levels of carbenicillin and piperacillin may be important in attempting to maintain adequate aminoglycoside serum levels.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6447998     DOI: 10.1093/ajcp/74.3.316

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  7 in total

1.  Effect of concomitant administration of piperacillin on the dispositions of netilmicin and tobramycin in patients with end-stage renal disease.

Authors:  C E Halstenson; C A Hirata; K L Heim-Duthoy; P A Abraham; G R Matzke
Journal:  Antimicrob Agents Chemother       Date:  1990-01       Impact factor: 5.191

2.  Effect of piperacillin on tobramycin pharmacokinetics in patients with normal renal function.

Authors:  A Lau; M Lee; S Flascha; R Prasad; R Sharifi
Journal:  Antimicrob Agents Chemother       Date:  1983-10       Impact factor: 5.191

3.  Comparative assessment of in vitro inactivation of gentamicin in the presence of carbenicillin by three different gentamicin assay methods.

Authors:  S C Ebert; J H Jorgensen; D J Drutz; W A Clementi
Journal:  J Clin Microbiol       Date:  1984-10       Impact factor: 5.948

4.  In vitro inactivation of aminoglycosides by apalcillin.

Authors:  D N Wright; D C Hale; B Saxon; J M Matsen
Journal:  Antimicrob Agents Chemother       Date:  1986-02       Impact factor: 5.191

5.  An in vivo assessment of the tobramycin/ticarcillin interaction in cystic fibrosis patients.

Authors:  G W Roberts; R L Nation; A O Jarvinen; A J Martin
Journal:  Br J Clin Pharmacol       Date:  1993-10       Impact factor: 4.335

6.  Hydroxylamine technique for in vitro prevention of penicillin inactivation of tobramycin.

Authors:  A J Falkowski; R J Creger
Journal:  Antimicrob Agents Chemother       Date:  1984-11       Impact factor: 5.191

Review 7.  Piperacillin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  B Holmes; D M Richards; R N Brogden; R C Heel
Journal:  Drugs       Date:  1984-11       Impact factor: 9.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.